Amakye, D., Robinson, D., Rose, K., Cho, Y.-J., Ligon, K. L., Sharp, T., … Kieran, M. (2013). DEVELOPMENT OF A FIVE-GENE HEDGEHOG SIGNATURE AS A PATIENT PRESELECTION TOOL FOR HEDGEHOG PATHWAY-TARGETED THERAPY IN MEDULLOBLASTOMA. In NEURO-ONCOLOGY (Vol. 15, pp. 33–34). Fort Lauderdale, FL: OXFORD UNIV PRESS INC.

Amakye, Dereck, Douglas Robinson, Kristine Rose, Yoon-Jae Cho, Keith L. Ligon, Thad Sharp, Yuichi Ando, et al. “DEVELOPMENT OF A FIVE-GENE HEDGEHOG SIGNATURE AS A PATIENT PRESELECTION TOOL FOR HEDGEHOG PATHWAY-TARGETED THERAPY IN MEDULLOBLASTOMA.” In NEURO-ONCOLOGY, 15:33–34. OXFORD UNIV PRESS INC, 2013.

Amakye D, Robinson D, Rose K, Cho Y-J, Ligon KL, Sharp T, et al. DEVELOPMENT OF A FIVE-GENE HEDGEHOG SIGNATURE AS A PATIENT PRESELECTION TOOL FOR HEDGEHOG PATHWAY-TARGETED THERAPY IN MEDULLOBLASTOMA. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2013. p. 33–4.

Amakye, Dereck, et al. “DEVELOPMENT OF A FIVE-GENE HEDGEHOG SIGNATURE AS A PATIENT PRESELECTION TOOL FOR HEDGEHOG PATHWAY-TARGETED THERAPY IN MEDULLOBLASTOMA.” NEURO-ONCOLOGY, vol. 15, OXFORD UNIV PRESS INC, 2013, pp. 33–34.

Amakye D, Robinson D, Rose K, Cho Y-J, Ligon KL, Sharp T, Ando Y, Geoerger B, Doz F, Ashley D, Hargrave D, Casanova M, Tawbi H, Heath J, Bouffet E, Brandes AA, Chisholm J, Rodon J, Thomas A, Mita A, MacDonald T, Kieran M. DEVELOPMENT OF A FIVE-GENE HEDGEHOG SIGNATURE AS A PATIENT PRESELECTION TOOL FOR HEDGEHOG PATHWAY-TARGETED THERAPY IN MEDULLOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2013. p. 33–34.